Cancer of the Pancreas Clinical Trial
Official title:
A Phase II Study of Pioglitazone for Patients With Cancer of the Pancreas
This study is being done to determine whether or not addition of the oral medication, pioglitazone to standard chemotherapy, results in improvement of blood tests that measure the body's ability to utilize sugar (glucose and insulin metabolism). In addition the investigators want to determine whether or not treatment with pioglitazone results in (1) improvement in the size of the tumor, (2) weight gain, (3) improved ability to function during the day and (4) quality of life.
n/a
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT01313416 -
Gemcitabine and CT-011 for Resected Pancreatic Cancer
|
Phase 2 | |
Recruiting |
NCT03323944 -
CAR T Cell Immunotherapy for Pancreatic Cancer
|
Phase 1 | |
Terminated |
NCT02669914 -
MEDI4736 (Durvalumab) in Patients With Brain Metastasis From Epithelial-derived Tumors
|
Phase 2 | |
Withdrawn |
NCT04123574 -
A Pilot Study of BXCL701 in Patients With Pancreatic Cancer
|
Early Phase 1 | |
Active, not recruiting |
NCT02905578 -
A Phase 2 Trial of High-dose Ascorbate for Pancreatic Cancer (PACMAN 2.1)
|
Phase 2 | |
Completed |
NCT01446458 -
Phase I Study of Stereotactic Body Radiation Therapy and FOLFIRINOX in the Neoadjuvant Therapy of Pancreatic Cancer
|
Phase 1 | |
Recruiting |
NCT05252390 -
NUV-868 as Monotherapy and in Combination With Olaparib or Enzalutamide in Adult Patients With Advanced Solid Tumors
|
Phase 1/Phase 2 | |
Completed |
NCT02311361 -
Immune Checkpoint Inhibition (Tremelimumab and/or MEDI4736) in Combination With Radiation Therapy in Patients With Unresectable Pancreatic Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT02681796 -
Epidural Analgesia Use in Pancreatic Resections
|
Phase 1 | |
Terminated |
NCT02608229 -
BVD-523 Plus Nab-paclitaxel and Gemcitabine in Patients With Metastatic Pancreatic Cancer
|
Phase 1 | |
Completed |
NCT03883919 -
Liposomal Irinotecan Plus 5-FU / LV Combined With Paricalcitol in Patients With Advanced Pancreatic Cancer Progressed on Gemcitabine-based Therapy
|
Phase 1 | |
Terminated |
NCT03122106 -
Neoantigen DNA Vaccine in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
|
Phase 1 | |
Terminated |
NCT00613730 -
Adenocarcinoma of the Pancreas Treated With Panitumumab and Gemcitabine Regimen to Investigate Overall Survival as Primary Endpoint
|
Phase 2 | |
Terminated |
NCT02950025 -
Daily Online Adaptation Versus Localization for MRI-Guided SBRT for Unresectable Primary or Oligometastatic Abdominal Malignancies
|
Phase 2 | |
Recruiting |
NCT03821025 -
Self-expandable Metal Stents Versus Multiple Plastic Stents for Palliation of Biliary Obstruction
|
N/A | |
Completed |
NCT04542291 -
Targeting Pancreatic Cancer With Sodium Glucose Transporter 2 (SGLT2) Inhibition
|
Phase 1 | |
Terminated |
NCT03956056 -
Neoantigen Peptide Vaccine Strategy in Pancreatic Cancer Patients Following Surgical Resection and Adjuvant Chemotherapy
|
Phase 1 | |
Recruiting |
NCT05975593 -
MicroEnvironment Tumor Effects of Radiotherapy - Comprehensive Radiobiology Assessment TRial
|
||
Recruiting |
NCT05111353 -
Neoantigen Vaccines in Pancreatic Cancer in the Window Prior to Surgery
|
Phase 1 | |
Terminated |
NCT02352831 -
Tosedostat With Capecitabine in Patients With Metastatic Pancreatic Adenocarcinoma
|
Phase 1/Phase 2 |